Mangalam Drugs and Organics logo

Mangalam Drugs and Organics financials and balance sheet

NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap

Last close ₹28.65down ₹0.92 (3.11%)BSE ₹28.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹29.57.

52-week range of traded prices to 23 Oct 2026
₹22.80Low, 29 Dec 2025₹71.99High, 23 Oct 2025
Market cap
₹45 Cr3,423rd largest listed
P/E
Lossover the last 12 months
P/B
0.4
Dividend yield
Nonein the last 12 months
ROE
−30.3%
ROCE
−12.9%
Debt to equity
1.02
Volume, NSE
19,55176.4% delivered

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Mangalam Drugs and Organics annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
A loss in the year to Mar 2026, −₹44 CrA loss in 3 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

The years either side of a change of basis do not compare. From the year to Mar 2018, the company's revenue for that year, ₹279 Cr, differs from its quarters added, ₹284 Cr. From the year to Mar 2022, the company's revenue for that year, ₹451 Cr, differs from its quarters added, ₹434 Cr.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue232
  2. Materials and goods−157
  3. Employee costs−33
  4. Other expenses−56
  5. Operating profit−15
  6. Depreciation−18
  7. Other income+0.8
  8. One-off items0.0
  9. Finance costs−16
  10. Profit before tax−48
  11. Tax+4.2
  12. Net profit−44

What the company owns

  • Plant, investments and other assets₹164 Cr
  • Inventory₹103 Cr
  • Receivables₹40 Cr
  • Cash and bank₹1 Cr

What pays for it: net worth and liabilities

  • Net worth₹103 Cr
  • Borrowings₹102 Cr
  • Owed to suppliers₹69 Cr
  • Other liabilities₹34 Cr

Profit and loss

Standalone, ₹ crore, years to March.Mangalam Drugs and Organics quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 10 MayMar 2020Filed 3 JulMar 2021Filed 21 MayMar 2022Filed 7 JunMar 2023Filed 31 MayMar 2024Filed 13 JunMar 2025Filed 12 JunMar 2026Filed 14 May
Revenue from operations313279228282380451372369318232
264233218259327402347351282247
Materials and goods bought182163153195252307251245167157
Employee costs–232626303735394133
Other expenses–463937455861687456
Operating profit before depreciation484710245349261736−15
Operating margin15.5%16.8%4.3%8.4%14.0%10.9%6.9%4.7%11.4%−6.3%
Materials, % of revenue–58.5%67.4%69.2%66.2%68.0%67.3%66.3%52.6%67.6%
Employee costs, % of revenue–8.2%11.3%9.2%7.9%8.3%9.3%10.6%12.8%14.4%
Other expenses, % of revenue–16.5%17.0%13.2%11.9%12.9%16.5%18.3%23.3%24.3%
Depreciation and amortisation577891011151618
Operating profit after depreciation4340315443915320−33
Other income0101500001
Finance costs101291091113141516
One-off items––00000000
Profit before tax3329−6640282−115−48
1092−21281−2−2−4
Net profit2420−8828201−97−44
Other comprehensive income––00−100−1−10
Total comprehensive income––−8827201−106−44
Net margin7.6%7.1%−3.5%2.9%7.4%4.4%0.3%−2.5%2.2%−18.9%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2017 they do not, so they are left blank.
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations95102112131154126123221295
8994102119139130113200257
Materials and goods bought7173819210910178156202
Employee costs344679–1114
Other expenses141717212419–3441
Operating profit before depreciation69101315−3102038
Operating margin6.5%8.6%9.3%9.5%9.6%−2.7%8.0%9.2%12.8%
Materials, % of revenue75.0%70.9%72.1%70.0%70.7%80.0%–70.6%68.4%
Employee costs, % of revenue3.4%3.6%3.8%4.2%4.4%7.5%–5.0%4.9%
Other expenses, % of revenue15.1%16.8%14.8%16.3%15.4%15.1%–15.2%14.0%
Depreciation and amortisation233344444
Operating profit after depreciation467911−761633
Other income000101000
Finance costs3567101010109
Profit before tax11231−17−4624
Tax01111−5−108
Net profit11121−12−3616
Net margin0.6%0.8%1.1%1.6%0.4%−9.3%−2.5%2.8%5.4%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 10 MayMar 2020Filed 3 JulMar 2021Filed 21 MayMar 2022Filed 7 JunMar 2023Filed 31 MayMar 2024Filed 13 JunMar 2025Filed 12 JunMar 2026Filed 14 May
96104131151152142149103
Share capital1616161616161616
Reserves808811513513612713387
59465867688881102
90109108135165181185189
2317244342342615
Total assets209231263328360357359308
104111131146153157160152
105119132182207200199156
Net debt58445765668779101
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 21 MayMar 2022Filed 7 JunMar 2023Filed 31 MayMar 2024Filed 13 JunMar 2025Filed 12 JunMar 2026Filed 14 May
27.530.739.512.242.94.2
36.839.539.512.042.84.5
−19.9−10.68.5−6.57.420.1
Receivables−13.67.80.019.7−11.1−1.2
Inventories6.3−58.5−20.4−13.8−15.236.0
Payables−13.911.242.512.48.3−22.5
Other working capital1.328.9−13.6−24.825.47.7
Tax paid−9.3−8.80.00.20.1−0.3
Capital spending31.427.727.917.920.211.9
Free cash flow−3.93.011.6−5.722.7−7.7
−31.3−27.3−22.2−17.919.5−11.7
2.7−2.0−16.65.7−21.75.7
Dividends paid0.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash−1.01.40.70.040.7−1.9
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020. Dividends received is left blank for the year to Mar 2025: the line is filed below nought and is smaller than the rounding of its section's total, so the statement does not show which way it moved cash.

Per share

Standalone, ₹ per share, years to March.Mangalam Drugs and Organics dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 10 MayMar 2020Filed 3 JulMar 2021Filed 21 MayMar 2022Filed 7 JunMar 2023Filed 31 MayMar 2024Filed 13 JunMar 2025Filed 12 JunMar 2026Filed 14 May
Earnings per share₹14.97₹12.57−₹5.07₹5.21₹17.67₹12.42₹0.80−₹5.72–−₹27.68
Diluted earnings per share₹14.97₹12.57−₹5.07₹5.21₹17.67₹12.42₹0.80−₹5.72–−₹27.68
Dividend per share–₹0.50––––––––
Book value per share––₹60.50₹65.67₹82.74₹95.12₹96.00₹89.93₹93.92₹65.28
Dividend payout–4.0%––––––––
Shareholder yield––––0.0%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)230257864815916215514611843
Earnings per share is left blank for the year to Mar 2025: the earnings per share stated does not match any profit the filing states over the shares in issue, and the share count barely moved during the period.
RatioMar 2017Mar 2018Mar 2019Filed 10 MayMar 2020Filed 3 JulMar 2021Filed 21 MayMar 2022Filed 7 JunMar 2023Filed 31 MayMar 2024Filed 13 JunMar 2025Filed 12 JunMar 2026Filed 14 May
Revenue growth5.9%–−18.5%24.1%34.6%–−17.5%−1.0%−13.7%−27.1%
Operating profit growth28.3%–−79.3%144.7%125.0%–−48.0%−31.8%107.8%–
Net profit growth47.8%−16.1%––238.9%−29.7%−93.5%–––
Earnings per share growth34.3%−16.0%––239.2%−29.7%−93.6%–––
––−8.4%8.3%23.8%14.0%0.8%−6.1%4.8%−34.8%
–––16.7 pts15.6 pts−9.9 pts−13.1 pts−7.0 pts10.9 pts−39.5 pts
From the net margin–––15.3 pts12.5 pts−9.7 pts−12.9 pts−6.9 pts11.6 pts−46.0 pts
From asset turnover–––1.2 pts4.2 pts−0.1 pts−0.3 pts0.3 pts−0.7 pts9.0 pts
From borrowing–––0.1 pts−1.1 pts0.0 pts0.1 pts−0.4 pts0.1 pts−2.5 pts
Return on capital employed––1.7%10.3%23.3%17.8%6.6%1.2%8.6%−15.8%
Cash conversion––––98.5%156.2%3,112.0%–619.9%–
Interest cover4.33.40.31.54.73.51.10.21.3–
Debt to equity––0.620.440.440.450.450.620.550.99
Receivable days––2852513846284563
Inventory days––17512185139200185303239
Payable days––771066265141124199160
Cash conversion cycle, days––126677511210488148142
Working capital days––10265727586929694
Asset turnover––1.091.281.541.531.081.030.890.70
Assets per rupee of net worth––2.182.202.102.102.272.442.462.65
Sales per rupee of plant––2.263.033.673.563.463.552.852.13
Capital spending to depreciation––––3.432.702.541.221.230.67
Plant being built, % of plant in use––0.2%1.3%6.1%0.1%5.9%0.0%0.0%0.0%
Revenue growth and operating profit growth are left blank for the years to Mar 2018 and Mar 2022: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. Interest cover is left blank for the year to Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
−13.1%
Measure10 years5 years3 years
Revenue growth, yearly rate−2.4%−9.4%−14.6%
Return on equity, average–−4.3%−12.1%
Return on capital employed, average–3.7%−2.0%
Operating margin, average8.6%5.5%3.2%
Net margin, average0.7%−2.9%−6.4%
Asset turnover, average–1.040.87
Cash conversion cycle, days, average–119126
Interest cover, average2.31.50.8
Debt to equity, average–0.610.72

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations129594
Cash from investing−60−10−12
Cash from financing−29−106
Capital spending1065012
Dividends paid000
Shares bought back000
Shares issued for cash000
Borrowings raised––0
Borrowings repaid382722

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––76657–
Altman Z-scorePublished threshold 1.81––2.212.283.503.062.29–––
Beneish M-scorePublished threshold −1.78––––−2.04−2.86−2.56−3.17––
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––12.855.51−4.67−0.92––
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––2.006.94––
Receivables growth less revenue growthOur threshold 0 percentage points–––102.71−0.60−31.9117.57−38.96––
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−39.14−38.5478.1035.65−7.61––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––0.071.71−0.510.807.10––
Assets under construction, years of additionsOur threshold 2 years of additions–––1.690.330.01–0.00––
Effective tax ratePublished threshold 17.16 per cent29.0232.23–−32.0029.2229.1242.63–––
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––−2.6441.45–––
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
24 Nov 2025CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesCrisil D (Issuer Not Cooperating)Review, Downgrade1.43
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.